Gerald (Jerry) Nepom received his A.B. magna cum laude (1972) from Harvard University and Ph.D. in Biochemistry (1977) and M.D. (1978) from the University of Washington (UW). After post-doctoral work in immunogenetics at Harvard Medical School, he joined the Fred Hutchinson Cancer Research Center and the University of Washington Medical School Faculty in 1982. Beginning in 1985, he founded the Immunology and Diabetes Research Programs at the Benaroya Research Institute at Virginia Mason (BRI), which now includes >250 staff with an annual budget of $65 million. Since 2010, he has also been the Director of the NIAID-sponsored Immune Tolerance Network (ITN), engaged in the design, implementation, and analysis of clinical trials and translational studies for transplantation, autoimmunity, and allergy. Dr. Nepom’s research interests are focused on identifying and understanding molecular and genetic mechanisms triggering of autoimmune disorders, particularly type 1 diabetes, rheumatoid arthritis, and multiple sclerosis, and on improving experimental therapies for prevention and intervention.
Dr. Nepom serves on numerous editorial boards and professional advisory boards related to molecular immunology, autoimmunity, and immunotherapy. He is a past president of the Federation of Clinical Immunology Societies (FOCIS) and his awards include the University of Washington School of Medicine Distinguished Alumni Award and the David Rumbaugh award from the Juvenile Diabetes Research Foundation. Dr. Nepom has published over 350 scientific papers in the areas of immunology, genetics, and autoimmunity.